ACXP vs BTAI (Acurx Pharmaceuticals Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Sep, 14 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Today's Session Official Close
The regular trading session has completed and official closing prices are verified as of 11:15 PM ET. All metrics below represent finalized session performance.
BTAI leads by +1.63% Alpha Spread Today
ACXP is trading at -2.52% while BTAI is at +-0.89% .
Started At
Official opening auction price
Closed At
Official exchange closing price
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | ACXP | BTAI | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | -2.52% | +-0.89% | BTAI +1.63% |
| Net Dollar Move | $-0.04 | +$-0.00 | BTAI higher move |
| Open Price | $1.39 | $0.04 | Gap: 0.00% vs -20.00% |
| Day High | $1.40 | $0.05 | Session peaks |
| Day Low | $1.35 | $0.04 | Session troughs |
| Intraday Spread | $0.05 | $0.01 | High/Low spread |
| Share Volume | 82.1K | 546.5K | BTAI more active |
| Est. Dollar Volume | $111.7K | $21.9K | ACXP higher liquidity |
Explore ACXP vs BTAI Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.